STEAP2 and Familial prostate cancer: Knockdown of STEAP2 significantly suppresses the proliferation of prostatic cancer, though current data suggest that this effect occurs probably due to STEAP2 ability to induce enzymatic activity that results in degradation of extracellular matrix (24, 27).